Phoenix, AZNCT05030298Now EnrollingIRB Ready

Malignant Glioma Clinical Trial in Phoenix, AZ

Access cutting-edge malignant glioma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Phoenix location

Preparing your pre-screening questions…

Expert Care in Phoenix

Access malignant glioma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related malignant glioma treatment provided free

Apply for This Phoenix Location

Check if you qualify for this malignant glioma clinical trial in Phoenix, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Phoenix

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Phoenix site if eligible
  4. 4Begin participation

About This Malignant Glioma Study in Phoenix

This phase I trial finds out the possible benefits and/or side effects of radiosurgery before surgery (preoperative) in treating patients with high grade glioma. Radiosurgery uses special equipment to position the patient and precisely give a single large dose of radiation to the tumor. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving pre-operative radiosurgery may improve the odds of brain tumor control and reduce treatment-related side effects.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

Age \>= 18 years
Clear clinical and radiographic evidence of primary high grade glioma (HGG) as judged by the Mayo multidisciplinary neuro-oncology team (World Health Organization \[WHO\] grade III-IV, including glioblastoma) regardless of IDH and MGMT status
Patients who underwent a previous biopsy confirming high grade glioma are eligible for enrollment
Planned neurosurgical resection of tumor
Judged to not be at risk of significant clinical risk (i.e. herniation) with radiation-induced edema prior to resection
Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
Negative pregnancy test done =\< 14 days prior to registration, for women of childbearing potential only. Patients over 50 years of age who decline pregnancy testing are still eligible without a pregnancy test.
Ability to complete questionnaire(s) by themselves or with assistance
Provide written informed consent
Willing to receive adjuvant radiotherapy at enrolling institution at the time of registration
Willing to provide tissue and/or blood samples for correlative research purposes

Exclusion Criteria

Any of the following:
Pregnant women
Nursing women who are unwilling to cease during therapy
Men or women of childbearing potential who are unwilling to employ adequate contraception
Prior history of cranial radiotherapy
Unwillingness to participate in study
Investigator discretion that enrollment on the study would pose undo harm or risk to the patient
Non-MRI compatible implanted medical device
Use of systemic anti-cancer therapy within the previous 3 months
Medical contraindication to craniotomy and tumor resection
Pathologic confirmation of grade I-II glioma, brain metastasis, or other brain tumor
Note: Patients with a history of grade I-II glioma are eligible if they have only received surgery as treatment and now there is concern for transformation to grade III-IV tumor
Primary spinal cord glioma or primary brainstem glioma
Residual tumor of excessive volume or eloquent location per investigator discretion
Patients who are unwilling or unable to comply with study procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Phoenix?

Yes, this clinical trial (NCT05030298) has an active research site in Phoenix, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Malignant Glioma Treatment Options in Phoenix, AZ

If you're searching for malignant glioma treatment options in Phoenix, AZ, this clinical trial (NCT05030298) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all malignant glioma clinical trials near you to find additional studies recruiting in your area.

More Brain Cancer Trials in Phoenix, AZ

See all brain cancer clinical trials recruiting in Phoenix — not just this study.

Browse Brain Cancer Trials in Phoenix →

Browse More Trials by Condition

Brain Cancer TrialsAll Conditions →

Ready to Join in Phoenix?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Phoenix, AZ